DEF 14ATELACIK 0001561921

TELA Bio, Inc.

Name: SEC EDGAR filing 0001104659-26-053117
Creator: TELA Bio, Inc.
License: https://www.usa.gov/government-works

Proxy statement (DEF 14A) filed April 30, 2026.

Definitive proxy statement disclosing matters to be voted on by shareholders, including executive compensation.

Open the filing on SEC.gov

New to the DEF 14A? What it is and how to read one

Filing facts

Accession number: 0001104659-26-053117
Filer: TELA Bio, Inc.
Ticker: TELA
CIK: 0001561921
Form type: DEF 14A
Form description: Proxy statement
Filed at: April 30, 2026
Industry: SIC 3841Surgical & Medical Instruments
Last verified: August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from TELA Bio, Inc.

See all 48 filings from TELA Bio, Inc. →

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1561921/000110465926053117/0001104659-26-053117-index.htm ↗

Filer's full EDGAR submission history

EDGAR · TELA Bio, Inc. (0001561921) ↗

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.